Bone Accrual in Males with Autism Spectrum Disorder

详细信息    查看全文

• 作者：Ann M. Neumeyer ; MD¹ ; ² ; ^{aneumeyer@mgh.harvard.edu} ; Natalia Cano Sokoloff ; MD¹ ; Erin McDonnell ; MS³ ; Eric A. Macklin ; PhD² ; ³ ; Christopher J. McDougle ; MD¹ ; ² ; Madhusmita Misra ; MD² ; ⁴
• 关键词：bone mineral density ; autism spectrum disorder
• 刊名：The Journal of Pediatrics
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：181
• 期：Complete
• 页码：195-201.e6
• 全文大小：684 K
• 卷排序：181

文摘

To test the hypothesis that bone accrual over a 4-year period is reduced in boys with autism spectrum disorder (ASD) compared with typically developing controls.Study designTwenty-five boys with ASD and 24 controls were assessed for bone outcomes. Fourteen boys with ASD and 11 controls were assessed both at baseline and after 4 years. The mean subject age was 11.0 ± 1.6 years at study initiation and 14.9 ± 1.6 years at follow-up. Bone mineral density (BMD) was measured at the spine, hip, and whole body using dual-energy X-ray absorptiometry and normalized for age, race, and sex (BMD z-scores). Height adjustments were performed as well. We assessed medical history, physical activity using questionnaires, vitamin D and calcium intake using food records, and serum calcium, phosphorus, 25(OH)-vitamin D, and pubertal hormone levels.ResultsBoys with ASD had lower spine, hip, and whole body BMD z-scores compared with controls. In those subjects assessed both at baseline and after 4 years, bone accrual rates did not differ between the 2 groups; however, spine and hip BMD z-scores remained lower in the boys with ASD than in controls at follow-up. Notably, the ASD group was less physically active at both time points.ConclusionAlthough pubertal bone accrual was similar to that in controls, BMD in children with ASD remained low over a 4-year follow-up period, suggesting that low BMD is a consequence of prepubertal factors, such as low physical activity. Studies are needed to investigate the causes and consequences of decreased BMD, to assess BMD in females and adults with ASD, and to evaluate therapeutic interventions.